Avita Medical | Los Gastos De Explotación



Operating Expenses Cambio Fecha
Adcock Ingram Holdings ZAR 4.42B 268.95M 2024-06
Celltrion KRW 674.25B 128.01B 2024-09
Clinuvel Pharmaceuticals AUD 20.71M 2.35M 2024-06
Cochlear AUD 917M 73.4M 2024-06
CSL USD 5.55B 108M 2024-06
Cspc Pharmaceutical CNY 5.42B 102.74M 2024-09
Dianthus Therapeutics USD 32.07M 8M 2024-09
Ecofibre AUD 12.31M 44.07M 2024-06
Kangmei Pharma CNY 1.46B 193.63M 2024-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 141M 9.11M 2024-06
Malin Corporation EUR 700K 1.6M 2024-06
Mayne Pharma AUD 103.54M 9.39M 2024-06
Medical Developments International AUD 10.35M 17.73M 2024-06
Nanosonics AUD 42.61M 34M 2024-06
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Opthea USD 98.17M 4.23M 2024-06
Organigram Holdings CAD 54.04M 9.62M 2024-12
Pacific Edge NZD 26.27M 12.77M 2024-09
Paradigm Biopharmaceuticals AUD 14.97M 35.18M 2024-06
Pharma Mar EUR 43.47M 3.3M 2024-12
Polynovo AUD 27.51M 19.08M 2024-06
PYC Therapeutics AUD 18.29M 5.76M 2024-06
Qiagen NV USD 377.04M 4.6M 2024-12
Ramsay Health Care AUD 8.35B 258.6M 2024-12
ResMed USD 864.85M 27.65M 2024-12
Sartorius EUR 725.4M 29M 2024-09
Sino Biopharmaceutical CNY 6.2B 2.04B 2024-06
Telix Pharmaceuticals AUD 321.98M 62.28M 2024-06
Tilray USD 253.17M 16.55M 2024-11
Zz Pientze Pharmaceu 1.67B 86.7M 2024-09



Avita Medical Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.